Tag: AMTX

TOMDF Run Continues

Todos Medical, Ltd. TOMDF

We have been tracking TOMDF since Tuesday morning in the premarket, when we included it in our extended watchlist. At the time, it was trading for as little as .0413 per share, and while it had a solid session that day, the gains hadn’t quite yet cracked the double-bag threshold.

Yesterday, after another really good performance, that mark was attained and then some. TOMDF has gone on to hit a new high of .17 for us, which works out to a big gain of 312%

The company’s rapid (2-10min) COVID-19 point-of-care test has been the primary reason for the stock’s huge moves. We will stay updated on the progress of the company getting the tests put into action, and will be interested to see if more upswings are on the horizon as a result.

Options Recaps

We signaled a range of options in the GILD chain in yesterday morning’s report. with the GILD Weekly $79-81 Calls. Thanks to a pretty good day for the markets, all things considered, we witnessed some very nice moves out of those targets.

Weekly $79-81 Calls
$79: 3.44-8.00 (+133%)
$80: 2.68-7.42 (+177%)
$81: 2.49-6.05 (+143%)
_____

Fresh Ideas:
CRWD Weekly $47.50-50 Calls & 03/27 $52-53.50 Calls

Extended Watchlist:
TNXP, NBP, WTRH, BLPH, AMTX, PIXY, CEMI

Blue Horseshoe Stocks: ADIL, AMTX Review

Adial Pharmaceuticals, Inc. ADIL

Just as we were lauding ADIL yesterday morning on its recent bucking of the terribly bearish trend that had been building for several weeks, we get that epic one day reversal and bullish surge in the markets. It was especially fortuitous timing in the case of ADIL, being that it was already up considerably. The added boost took the stock to new heights, and added considerably to the positive movement we’ve witnessed over the past couple of weeks.

At the time of our initial alert on ADIL on the morning of the 13th, we saw trades going off as low as 2.55. As of yesterday’s new high mark set at 7.45, which represents a two week upswing of 192%

Aemetis, Inc. AMTX

As for the the other mention from yesterday’s premarket report, AMTX, it too felt the effects of the huge rally in the markets, trading up from a low of .60, up as high as .97. That worked out to an intraday push of 62%

Regardless of the market conditions, we’ll have a slot on our watch screens reserved for AMTX going forward, after the company just received a considerable round of non-toxic financing to effect the execution of the next phase of its business plan.


DVB Technologies, Inc. DVBT

Among the countless stocks that have been at or near their annual lows recently, we want to highlight DVBT, to watch going forward. There is a considerable gap on the chart which the stock has been beginning to fill. The opportunity for a considerable swing trade may be present, provided that yesterday’s activity wasn’t merely an isolated event in the midst of a continued downward trajectory for the markets in general.

In addition to the stock itself, we’ll also go ahead and signal some options to watch, specifically the DVBT 05/17 $7.50 & $10 Calls.
____

Another Fresh Idea:
International Flavors & Fragrances, Inc. IFF 02/15 $130 & $135

Extended Watchlist:
SESN, SBGL, LILAK, PSTI, MYSZ, WFT, TVIX

Blue Horseshoe Stocks: ADIL Update

Adial Pharmaceuticals, Inc. ADIL

It has been an absolutely awful end to 2018, with a market bloodbath beginning roughly six weeks ago and amounting to perhaps the worst conditions we’ve seen in a decade. Despite that fact, with most big-board stock hovering at or near their annual lows, we have still managed to find a few plays that have bucked the trend.

One such stock is ADIL, which we signaled a couple weeks back on the morning of the 13th. That day, the stock was trading for as little as 2.55 a share. It has mainly experienced bullish activity even as everything around it has been going the opposite way. On Monday ADIL reached a new high of 5.75, marking a move of 125% in a span of two weeks.

Aemetis, Inc. AMTX

If you’re searching for a bottom play, you won’t have far to look in this market, as we just mentioned above. However, among all these bottom-feeding stocks we’ve got AMTX, which has a compelling reason to perhaps begin to recover some ground.

This morning, the company announced a huge round of non-toxic funding which is going to allow it to begin implementing a key element of its strategy in the New Year. We’re going to place AMTX on watch into 2019, especially with the company having a conference call scheduled for the second week in January. Things could get interesting between now and then thanks to this morning’s news.

CUPERTINO, CA, Dec. 26, 2018 (GLOBE NEWSWIRE) Aemetis, Inc. (AMTX) announced today that its subsidiary, Aemetis Biogas LLC, closed a $30 million equity investment without any dilute stock issuance by Aemetis, Inc. and funded the first $8.3 million tranche to subsidiary Aemetis Biogas to build, own and operate dairy biomethane digesters, pipelines and gas cleanup/compression facilities primarily under 20-year agreements with dairy farms in California (>>View Full PR)

Extended Watchlist:
ROKU, ESES, GNMK, CTT, MRIN, TRXC, INPX, HSGX